Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2020) on “Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines”. Flucelvax® Quad is a mammalian cell culture-based, inactivated seasonal influenza vaccine that has recently been authorized for use in Canada in adults and children ≥9 years of age.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.